ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 308

Frequency, Morbidity and Healthcare Utilization of Diffuse Idiopathic Skeletal Hyperostosis (DISH) Patients at a University Hospital

Maanas Tripathi1, Divya Rajmohan2, Cody Quirk3, Brooke Beckett3, Donseok Choi4, Neha Rich-Garg5 and Atul A. Deodhar4, 1University of Miami, FL, Miami, FL, 2Oregon Health & Sciences University, Portland, OR, 3Radiology, Oregon Health & Science University, Portland, OR, 4Oregon Health & Science University, Portland, OR, 5Northwest Rheumatology Assoc., Portland, OR

Meeting: 2017 ACR/ARHP Annual Meeting

Date of first publication: September 18, 2017

Keywords: diffuse idiopathic skeletal hyperostosis (DISH) and morbidity and mortality, Imaging

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Sunday, November 5, 2017

Title: Orthopedics, Low Back Pain and Rehabilitation Poster

Session Type: ACR Poster Session A

Session Time: 9:00AM-11:00AM

Background/Purpose:

DISH is a non-inflammatory condition affecting the spine, and characterized by ossification of paravertebral ligaments. DISH is traditionally considered asymptomatic, detected incidentally on spine radiographs. We investigated the frequency of DISH diagnosis, the associated morbidity and healthcare utilization by patients attending our university hospital.

Methods:

Our University’s radiology database was searched from years 2005 to 2015 for the words “DISH” or “diffuse idiopathic skeletal hyperostosis” in the recorded results of spinal radiographs. Patients from the year 2015 whose spinal radiographs mentioned these words were selected for further analysis. Their spinal radiographs were re-read by two authors. Patients were divided into those who fulfilled the Resnick Criteria for DISH (Group A), and those who did not fully meet the criteria but had radiographic features suggestive of DISH (Group B). Means and proportions were used to describe variables, for group comparisons, T-test and c2 were used. A p-value less than 0.05 was considered statistically significant. All computations were done in the R statistical program.

Results:

Between 2005-2015, 3439 radiology records had DISH mentioned as a diagnosis. Out of 196 patients diagnosed with DISH In 2015, 153 fulfilled the Resnick criteria (Group A), 41 didn’t fulfill the criteria but were diagnosed as DISH by the radiologists (Group B), and 2 had erroneous diagnoses. The Table shows the comparison between the two groups. Thoracic radiographs where DISH was mentioned were more likely to fulfill the Resnick criteria than not (35% vs 15%) compared to other radiographs (p < 0.03). Chronic back pain was very common in both groups, and more often reported in Group B than Group A (81% vs. 63%, p = 0.04). Back pain was the reason for performing the initial diagnostic radiograph in 45% of Group A and 61% of Group B. A substantial portion of patients required opioid medications for pain control (51%), spinal surgery (31%), and consultations with various specialists for regional pain (57%). Health care interventions were similar in both groups.

Conclusion:

DISH is a common diagnosis with significant morbidity, despite being commonly considered to be an asymptomatic condition. Majority of DISH patients had chronic back pain, required opioid medication, and a large proportion required spinal surgery. Future research is needed to systematically assess the healthcare utilization by DISH patients.

Table: Comparison of DISH patients: those fulfilling Resnick criteria vs. not fulfilling Resnick criteria but diagnosed by radiologists (ns = not significant)

Variable

Group A: Resnick Criteria fulfilled (n = 153)

Group B: Resnick Criteria not fulfilled (n = 41)

p

Age in years (mean)

70.6

62.4

p < 0.01

Male Gender

110

(72%)

33

(28%)

p = ns

BMI

32.34

32.83

p = ns

Chronic Back Pain

96 (63%)

33 (81%)

p = 0.04

Type 2 Diabetes Mellitus

19 (12%)

3 (7%)

p = ns

Hypertension

33 (22%)

8 (20%)

p = ns

Hyperlipidemia

19 (12%)

5 (12%)

p=ns

Gout

10 (7%)

2 (5%)

p = ns

Type of Radiograph

Spinal Survey

Cervical

Thoracolumbar

Thoracic

Lumbar

Sacroiliac

2 (1%)

12 (8%)

11 (22%)

53 (35%)

68 (45%)

3 (2%)

1 (3%)

6 (15%)

0 (NA)

6 (15%)

26 (66%)

0 (NA)

p = 0.03

Reason for X-ray

DISH

Pain

Other

5 (3.3%)

69 (45%)

78 (51%)

0 (NA)

25 (61%)

16 (39%)

Pearson’s c2

p = ns

Opioid Use

77 (54%)

22 (50%)

p = ns

Bisphosphonate Use

1 (1%)

0 (0%)

p =ns

Spinal Surgery

46 (31%)

14 (34%)

p = ns

Spinal Pumps

1 (1%)

0 (0%)

p =ns

Consultations

Neurology

Orthopedics

Rheumatology

Physical Medicine and Rehabilitation

8 (6%)

59 (42%)

7 (5%)

5 (4%)

3 (8%)

23 (59%)

2 (5%)

1 (3%)

p = ns


Disclosure: M. Tripathi, None; D. Rajmohan, None; C. Quirk, None; B. Beckett, None; D. Choi, None; N. Rich-Garg, Pfizer Inc, 2; A. A. Deodhar, AbbVie, Amgen, Eli Lilly, GlaxoSmithKline, Janssen, Novartis, Pfizer, UCB Pharma, 2,Eli Lilly, Janssen, Novartis, Pfizer, UCB Pharma, 2.

To cite this abstract in AMA style:

Tripathi M, Rajmohan D, Quirk C, Beckett B, Choi D, Rich-Garg N, Deodhar AA. Frequency, Morbidity and Healthcare Utilization of Diffuse Idiopathic Skeletal Hyperostosis (DISH) Patients at a University Hospital [abstract]. Arthritis Rheumatol. 2017; 69 (suppl 10). https://acrabstracts.org/abstract/frequency-morbidity-and-healthcare-utilization-of-diffuse-idiopathic-skeletal-hyperostosis-dish-patients-at-a-university-hospital/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2017 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/frequency-morbidity-and-healthcare-utilization-of-diffuse-idiopathic-skeletal-hyperostosis-dish-patients-at-a-university-hospital/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology